drugset / Trial / NCT05309499

An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function

NCT05309499 ↗

Completed 298 enrolled Kazan State Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

The OPERA-MI trial evaluates the effect of i.v. ferric carboxymaltose compared to the effect of oral iron, on left ventricular systolic function.

Timeline

Start
2021-12-05
Primary completion
2025-09-15
Completion
2025-09-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferric carboxymaltose Other / unclassified — Intravenous
Comparator Ferrous Sulfate Diagnostic / imaging agent 100 mg Oral